Microbial adaptation of Pseudomonas lipid A structure in CF airway disease progress

假单胞菌脂质 A 结构在 CF 气道疾病进展中的微生物适应

基本信息

  • 批准号:
    10722599
  • 负责人:
  • 金额:
    $ 23.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Persistent acute inflammation and chronic infection are hallmarks of Cystic Fibrosis (CF) pulmonary disease. Bacterial infections cause much of the damage seen in CF patients’ airways. Chronic colonization by Pseudo- monas aeruginosa (Pa) is strongly associated with disease progression and mortality due to the activation of the host innate immune system. Innate immune cells drive this strong inflammation but paradoxically fail to clear pathogens such as Pa. We have previously shown that Pa isolated from children with CF have unique lipid A structures; one of the earliest adaptations to the CF airway. Lipid A is the membrane anchor of lipopoly- saccharide (LPS) and is responsible for endotoxemia, localized tissue destruction, and septic shock. In addi- tion to early adaptation to the CF airway, a highly pro-inflammatory, hyper-acylated lipid A structure is ob- served in approximately one third of Pa isolated from patients with severe airway disease. The synthesis of specific lipid A structures is essential to CF lung disease pathogenesis as products of inflammation, derived from infiltrating host immune cells, such as neutrophils, are required for Pa to grow anaerobically in the thick and poorly oxygenated mucus of the CF lung. The overall goals of this proposal will strengthen and extend our hypothesis that during adaptation to the CF airway, Pa synthesizes CF-specific lipid A that alters host innate immune mechanisms, leading to persistence and chronic infection of the CF airways and that regulation of the neutrophil response could serve as a control mechanism for severe airway disease. The aims in this proposal will first, determine pathogenicity and signaling potential of defined Pa lipid A structures in rele- vant mouse models and CF bronchial epithelial cell lines and, second, map and assign structure to pro-inflam- matory Pa lipid A as it accumulates and distributes during the onset of lung pathology using mass spectrometry imaging. By defining how Pa lipid A structures condition the host for persistence, we will identify novel host- directed therapy (HDT) targets.
项目摘要 持续的急性炎症和慢性感染是囊性纤维化(CF)肺病的标志。 细菌感染导致CF患者气道中的大部分损伤。慢性定植的伪- 铜绿假单胞菌(Pa)与疾病进展和死亡率密切相关, 宿主的先天免疫系统先天免疫细胞驱动这种强烈的炎症,但矛盾的是, 明确病原体,如Pa.我们以前已经证明,从CF儿童中分离出的Pa具有独特的 脂质A结构; CF气道的最早适应之一。脂质A是脂多糖的膜锚, 糖(LPS),并导致内毒素血症、局部组织破坏和败血性休克。此外, 为了早期适应CF气道,观察到高度促炎性、超酰化的脂质A结构, 在大约三分之一的严重气道疾病患者中分离出Pa。的合成 特定的脂质A结构是CF肺病发病机制所必需的,作为炎症产物, 从浸润宿主免疫细胞,如嗜中性粒细胞,需要Pa在厚的厌氧生长。 以及CF肺的含氧粘液不足。该提案的总体目标将加强和扩大我们的 假设在适应CF气道期间,Pa合成CF特异性脂质A,改变宿主 先天免疫机制,导致CF气道的持续性和慢性感染, 中性粒细胞反应的调节可以作为严重气道疾病的控制机制。目标 在该提议中,将首先确定确定致病性和确定的Pa脂质A结构在rele中的信号传导潜力, vant小鼠模型和CF支气管上皮细胞系,第二,映射和分配结构,以pro-inflam- 使用质谱法测定炎性Pa脂质A在肺病理学发作期间的累积和分布 显像通过定义Pa脂质A结构如何调节宿主的持久性,我们将鉴定新的宿主- 定向治疗(HDT)的目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert K Ernst其他文献

Robert K Ernst的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert K Ernst', 18)}}的其他基金

Mid-Atlantic Microbial Pathogenesis Meeting 2022
2022 年大西洋中部微生物发病机制会议
  • 批准号:
    10504721
  • 财政年份:
    2022
  • 资助金额:
    $ 23.18万
  • 项目类别:
MS Diagnostic Bacterial Identification Library
MS 诊断细菌鉴定库
  • 批准号:
    10116273
  • 财政年份:
    2020
  • 资助金额:
    $ 23.18万
  • 项目类别:
MS Diagnostic Bacterial Identification Library
MS 诊断细菌鉴定库
  • 批准号:
    10356152
  • 财政年份:
    2020
  • 资助金额:
    $ 23.18万
  • 项目类别:
MS Diagnostic Bacterial Identification Library
MS 诊断细菌鉴定库
  • 批准号:
    10570981
  • 财政年份:
    2020
  • 资助金额:
    $ 23.18万
  • 项目类别:
Protection Against Gram-Negative Sepsis Conferred by Lipid A-Based Structural Variants
基于脂质 A 的结构变体可预防革兰氏阴性脓毒症
  • 批准号:
    9753900
  • 财政年份:
    2016
  • 资助金额:
    $ 23.18万
  • 项目类别:
MS diagnostic bacterial identification library
MS诊断细菌鉴定文库
  • 批准号:
    8722128
  • 财政年份:
    2014
  • 资助金额:
    $ 23.18万
  • 项目类别:
Development of a Rationally Attenuated Live Vaccine for Francisella tularensis
土拉弗朗西斯菌合理减毒活疫苗的研制
  • 批准号:
    8650788
  • 财政年份:
    2013
  • 资助金额:
    $ 23.18万
  • 项目类别:
Development of a Rationally Attenuated Live Vaccine for Francisella tularensis
土拉弗朗西斯菌合理减毒活疫苗的研制
  • 批准号:
    8511015
  • 财政年份:
    2013
  • 资助金额:
    $ 23.18万
  • 项目类别:
Immunotherapeutic Potential of Modified Lipooligosaccharides and Lipid A's
修饰脂寡糖和脂质 A 的免疫治疗潜力
  • 批准号:
    8675799
  • 财政年份:
    2013
  • 资助金额:
    $ 23.18万
  • 项目类别:
Immunotherapeutic Potential of Modified Lipooligosaccharides and Lipid A's
修饰脂寡糖和脂质 A 的免疫治疗潜力
  • 批准号:
    8584054
  • 财政年份:
    2013
  • 资助金额:
    $ 23.18万
  • 项目类别:

相似海外基金

Greasing endocytosis in plants - understanding the role of S-acylation in receptor kinase function and internalisation
植物中的润滑内吞作用 - 了解 S-酰化在受体激酶功能和内化中的作用
  • 批准号:
    BB/Y003756/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Research Grant
Ghrelin de-acylation inhibitors as novel compounds for Parkinson's dementia
生长素释放肽去酰化抑制剂作为治疗帕金森痴呆症的新型化合物
  • 批准号:
    MR/Y503435/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Research Grant
S-acylation-dependent regulation of cytokine receptor signaling and cardiac maladaptation
细胞因子受体信号传导和心脏适应不良的 S-酰化依赖性调节
  • 批准号:
    10561406
  • 财政年份:
    2023
  • 资助金额:
    $ 23.18万
  • 项目类别:
Comprehensive analysis of acidic patch binder using histone acylation catalysts
使用组蛋白酰化催化剂综合分析酸性贴片粘合剂
  • 批准号:
    22KJ1113
  • 财政年份:
    2023
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
S-Acylation of transmembrane proteins in the early secretory pathway
早期分泌途径中跨膜蛋白的 S-酰化
  • 批准号:
    BB/X001504/1
  • 财政年份:
    2023
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Research Grant
N-terminal acylation and sorting of Helicobacter pylori lipoproteins and their role in host response to infection
幽门螺杆菌脂蛋白的 N 末端酰化和分选及其在宿主感染反应中的作用
  • 批准号:
    10584620
  • 财政年份:
    2022
  • 资助金额:
    $ 23.18万
  • 项目类别:
The Molecular Mechanisms of Glycolytic Enzyme S-acylation in Neurons
神经元糖酵解酶S-酰化的分子机制
  • 批准号:
    576016-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Anti-CRISPR-mediated Acylation and Bioreversible Esterification for Precision Genome Editing
用于精准基因组编辑的抗 CRISPR 介导的酰化和生物可逆酯化
  • 批准号:
    10657417
  • 财政年份:
    2022
  • 资助金额:
    $ 23.18万
  • 项目类别:
High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader
YEATS2 组蛋白酰化酶抑制剂的高通量筛选
  • 批准号:
    10389517
  • 财政年份:
    2022
  • 资助金额:
    $ 23.18万
  • 项目类别:
Roles of KAT8 complexes in governing histone acylation and mouse cerebral development
KAT8复合物在控制组蛋白酰化和小鼠大脑发育中的作用
  • 批准号:
    RGPIN-2019-07122
  • 财政年份:
    2022
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了